# Oxyrane UK

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxyrane-uk

- Industry: Biotechnology
- Headquarters: Manchester, UK
- Website: www.oxyrane.com
- Total disclosed funding: $27M
- Latest round: Series D (Nov 17, 2011)
- Investors on record: 3

## About

Oxyrane UK is a biopharmaceutical company dedicated to the development of novel and biosuperior enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than 40 rare, inherited diseases. Founded in 2006, the company is headquartered in Manchester, United Kingdom with research facilities in Ghent, Belgium.

## Funding rounds

- Series D, Nov 17, 2011, $27M — Forbion, 5Y Capital, New Science Ventures

## Investors

- Forbion (https://capitalatlas.ai/funds/forbion) — Series D
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series D
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series D